SNNAF yields 3159.56% · MRK yields 2.76%● Live data
📍 SNNAF pulled ahead of the other in Year 1
Combined, SNNAF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNNAF + MRK for your $10,000?
Sienna Resources Inc. engages in the identification, acquisition, and exploration of mineral properties in Canada, Sweden, Finland, Norway, and the United States. The company primarily explores for platinum, palladium, nickel, copper, cobalt, and lithium deposits. It holds interests in the Slättberg project located in southern Sweden. The company also holds interests in Kuusamo PGE-Ni-Cu-Co project, Finland; Clayton Valley Deep Basin Lithium Brine project, North America; and Marathon North Platinum-Palladium Property covering an area of approximately 16,500 acres and located in Northern Ontario, Canada. In addition, it holds interest in the Blue Clay lithium project covering an area of approximately 2,950 acres located in the Clayton Valley of Nevada; and White Gold project located in Yukon, Canada. The company was formerly known as Habanero Resources Inc. and changed its name to Sienna Resources Inc. in January 2014. Sienna Resources Inc. was incorporated in 1983 and is headquartered in Vancouver, Canada.
Full SNNAF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.